Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -190.81% is 67% above its 5-year average of -580.90%, near the high end of its 5-year range (-2094.12%–-31.63%).
59.97% above its 12-month average of -476.65%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -47.37%.
RETURN ON ASSETS (ROA)
-190.81%
RETURN ON ASSETS (ROA) AVG TTM
-476.65%
RETURN ON ASSETS (ROA) AVG 3Y
-339.92%
RETURN ON ASSETS (ROA) AVG 5Y
-580.90%
RETURN ON ASSETS (ROA) AVG 10Y
-1009.59%
RETURN ON ASSETS (ROA) AVG 15Y
-104.38%
RETURN ON ASSETS (ROA) AVG 20Y
-14.91%
CURRENT VS TTM AVG
+59.97%
CURRENT VS 3Y AVG
+43.87%
CURRENT VS 5Y AVG
+67.15%
CURRENT VS 10Y AVG
+81.10%
CURRENT VS 15Y AVG
-82.80%
CURRENT VS 20Y AVG
-1179.58%
SECTOR MEDIAN · HEALTHCARE
-30.70%
median of 713 covered companies
CURRENT VS SECTOR MEDIAN
-521.53%
vs the sector median at left
HeartBeam, Inc.
Market Cap
$32.32M
Return on Assets (ROA)
-190.81%
TTM Avg
-476.65%
3Y Avg
-339.92%
5Y Avg
-580.90%
Market Cap
$32.14M
Return on Assets (ROA)
-39.14%
TTM Avg
-11.59%
3Y Avg
6.23%
5Y Avg
18.56%
Market Cap
$31.93M
Return on Assets (ROA)
-8.99%
TTM Avg
-5.06%
3Y Avg
-16.59%
5Y Avg
-28.89%
Market Cap
$32.76M
Return on Assets (ROA)
-277.36%
TTM Avg
-524.61%
3Y Avg
-478.10%
5Y Avg
-316.43%
Market Cap
$31.77M
Return on Assets (ROA)
1.29%
TTM Avg
-1.07%
3Y Avg
2.48%
5Y Avg
2.98%
Market Cap
$31.20M
Return on Assets (ROA)
-115.56%
TTM Avg
-181.38%
3Y Avg
-357.07%
5Y Avg
-299.51%
Market Cap
$30.90M
Return on Assets (ROA)
-99.62%
TTM Avg
-39.99%
3Y Avg
-67.06%
5Y Avg
188.84%
Market Cap
$30.83M
Return on Assets (ROA)
-22.66%
TTM Avg
-23.43%
3Y Avg
-29.30%
5Y Avg
-40.97%
Market Cap
$33.93M
Return on Assets (ROA)
-114.53%
TTM Avg
-107.26%
3Y Avg
-84.46%
5Y Avg
-72.21%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HeartBeam, Inc. (BEAT) | $32.32M | -190.81% | -476.65% | -339.92% | -580.90% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $32.14M | -39.14% | -11.59% | 6.23% | 18.56% |
| Rockwell Medical, Inc. (RMTI)vs › | $31.93M | -8.99% | -5.06% | -16.59% | -28.89% |
| EUDA Health Holdings Limited (EUDA)vs › | $32.76M | -277.36% | -524.61% | -478.10% | -316.43% |
| Nortech Systems Incorporated (NSYS)vs › | $31.77M | 1.29% | -1.07% | 2.48% | 2.98% |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $31.20M | -115.56% | -181.38% | -357.07% | -299.51% |
| Context Therapeutics Inc. (CNTX)vs › | $30.90M | -99.62% | -39.99% | -67.06% | 188.84% |
| MDxHealth S.A. (MDXH)vs › | $30.83M | -22.66% | -23.43% | -29.30% | -40.97% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.93M | -114.53% | -107.26% | -84.46% | -72.21% |
| BeyondSpring Inc. (BYSI)vs › | $30.58M | -45.77% | -31.61% | -54.99% | -58.45% |
ROA
-190.8%
ROE
-248.2%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -359.66% |
| 2024-12-31 | -593.65% |
| 2023-12-31 | -85.45% |
| 2022-12-31 | -320.92% |
| 2021-12-31 | -31.63% |
| 2020-12-31 | -2094.12% |
| 2019-12-31 | -7657.14% |
| 2018-12-31 | 7.30% |
| 2017-12-31 | -3.04% |
| 2016-12-31 | 26.85% |
| 2015-12-31 | 5.98% |
| 2014-12-31 | -7.85% |
| 2013-12-31 | -8.36% |
| 2012-12-31 | -13.56% |
| 2011-12-31 | -64.67% |
| 2010-12-31 | -12.67% |
| 2009-12-31 | -12.16% |
| 2008-12-31 | 5.55% |
| 2007-12-31 | -0.35% |
| 2006-12-31 | -44.53% |
| 2005-12-31 | 0.00% |
| 2004-12-31 | -91.86% |
| 2003-12-31 | -57.24% |
